Effects of fasudil on hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats

被引：5
|
作者：
Sun, X. -Z. [1 ]
Tian, X. -Y. [2 ]
Wang, D. -W. [3 ]
Li, J. [3 ]
机构：
[1] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Pediat, Huaian, Peoples R China
[2] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Neurol, Huaian, Peoples R China
[3] Nanjing Med Univ, Affiliated Nanjing Childrens Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China
来源：
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES | 2014年 / 18卷 / 07期
关键词：
Fasudil; Pulmonary arterial hypertension (PAH); Pulmonary vascular remodeling; RHO-KINASE INHIBITOR; THERAPEUTIC TARGET;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
AIM: The aim of this study was to investigate the effects of Rho kinase inhibitor-Fasudil on hypoxic pulmonary hypertension (HPH) and pulmonary vascular remodeling in rats. MATERIALS AND METHODS: A total of 24 Sprague Dawley rats were evenly randomized into control, model and Fasudil intervention groups. Light and transmission electron microscopy were utilized to observe pulmonary vascular remodeling as well as ultrastructural changes in pulmonary arteriole endothelial cells. RESULTS: The model group showed apparent pulmonary vascular remodeling, pulmonary arteriole endothelial cell injury, the proliferation and swelling of smooth muscle cells around, and the proliferation of collagen fibers. Fasudil intervention improved pulmonary vascular remodeling as well as relieved pulmonary arteriole endothelial cell injury and the proliferation of smooth muscle cells and collagen fibers. CONCLUSIONS: Fasudil has preventive and reverse effects on HPH, pulmonary vascular remodeling, and pulmonary arteriole endothelial cell injury.
引用
下载
收藏
页码：959 / 964
页数：6
相关论文
共 50 条
  • [41] PULMONARY VASCULAR REMODELING IN NEONATAL PULMONARY-HYPERTENSION
    HAWORTH, SG
    JOURNAL OF PHYSIOLOGY-LONDON, 1995, 487P : S12 - S13
  • [42] Vascular remodeling versus vasoconstriction in chronic hypoxic pulmonary hypertension - A time for reappraisal?
    Stenmark, KR
    McMurtry, IF
    CIRCULATION RESEARCH, 2005, 97 (02) : 95 - 98
  • [43] Functions of serotonin in hypoxic pulmonary vascular remodeling
    Juan M. Esteve
    Jean-Marie Launay
    Odile Kellermann
    Luc Maroteaux
    Cell Biochemistry and Biophysics, 2007, 47 : 33 - 43
  • [44] Bone morphogenetic protein 4 promotes vascular remodeling in hypoxic pulmonary hypertension
    Frank, D
    Johnson, J
    de Caestecker, M
    CHEST, 2005, 128 (06) : 590S - 591S
  • [45] Correlation between Platelet-Derived Growth Factor-BB and Pulmonary Vascular Remodeling in Neonatal Rats with Hypoxic Pulmonary Hypertension
    Bayiercaicike
    Li, Mingxia
    Wang, Le
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (01): : 423 - 431
  • [46] Effects of fasudil on pulmonary hypertension in clinical practice
    Zhang, Yiqing
    Wu, Shangjie
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 : 54 - 63
  • [47] Functions of serotonin in hypoxic pulmonary vascular remodeling
    Esteve, Juan M.
    Launay, Jean-Marie
    Kellermann, Odile
    Maroteaux, Luc
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2007, 47 (01) : 33 - 43
  • [48] Reversal of pulmonary vascular remodeling in pulmonary hypertensive rats
    Sluiter, Ilona
    van Heijst, Arno
    Haasdijk, Remco
    Buscop-van Kempen, Marjon
    Boerema-de Munck, Anne
    Reiss, Irwin
    Tibboel, Dick
    Rottier, Robbert J.
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2012, 93 (01) : 66 - 73
  • [49] Effect of Rho kinase inhibitor fasudil on the expression ET-1 and NO in rats with hypoxic pulmonary hypertension
    Sun, Xing-Zhen
    Li, Shu-Yan
    Tian, Xiang-Yang
    Hong, Ze
    Li, Jia-Xin
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2019, 71 (01) : 3 - 8
  • [50] Inhibition of tissue angiotensin-converting enzyme with quinapril reduces hypoxic pulmonary hypertension and pulmonary vascular remodeling
    Nong, ZX
    Stassen, JM
    Moons, L
    Collen, D
    Janssens, S
    CIRCULATION, 1996, 94 (08) : 1941 - 1947
12345